Publications by authors named "Virginia Volpe"

Claim this Profile
N
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.
H Moses Murdock, Haesook T Kim, Katie Maurer, Amar H Kelkar, Roman M Shapiro, Virginia O Volpe

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.
Emma-Jayne Minihane, Leah Krotee, Jason Wu, Lindsey Thornton, Geoffrey Fell, Virginia O Volpe

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasm.
Zhuoer Xie, Najla Al Ali, Ling Zhang, Peter Papenhausen, Virginia Olivia Volpe

Blood Neoplasia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia.
Akriti G Jain, Virginia O Volpe, Chen Wang, Somedeb Ball, Katherine Tobon

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia.
Abi Vijenthira, Virginia O Volpe, Aswin Sekar, Roberta Santos Azevedo, Mariia Mikhaleva

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
Claudia Pérez Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Virginia Volpe

Am J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
Luis E Aguirre, Akriti Jain, Somedeb Ball, Najla Al Ali, Virginia O Volpe

Clin Lymphoma Myeloma Leuk· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOHO State of the Art Updates and Next Questions: Treatment of Lower Risk Myelodysplastic Syndromes.
Virginia O Volpe, Guillermo Garcia-Manero, Rami S Komrokji

Clin Lymphoma Myeloma Leuk· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.
Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, Hannah Newman, Virginia Volpe

Blood Cancer Discov· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes.
Virginia O Volpe, Najla Al Ali, Onyee Chan, Eric Padron, David A Sallman

Br J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic Syndromes: A New Decade.
Virginia O Volpe, Guillermo Garcia-Manero, Rami S Komrokji

Clin Lymphoma Myeloma Leuk· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC overexpression is associated with an early disease progression from MDS to AML.
David Gajzer, Constantine N Logothetis, David A Sallman, Gregoire Calon, Abida Babu, Virginia O Volpe

Leuk Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes.
Rami Komrokji, Virginia Volpe, Onyee Chan, Najla Al Ali, David Swoboda

Blood· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment options for lower-risk myelodysplastic syndromes. Where are we now?
Virginia O Volpe, Rami S Komrokji

Ther Adv Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, Matthew S Davids, Virginia O Volpe

Clin Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new paradigm of systemic therapies for metastatic melanoma.
Virginia O Volpe, Daniel M Klufas, Upendra Hegde, Jane M Grant-Kels

J Am Acad Dermatol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis